0.8 |
2.4 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
0.6 |
1.7 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) olefin metabolic process(GO:1900673) |
0.6 |
1.7 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
0.5 |
1.9 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
0.4 |
1.2 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
0.3 |
1.4 |
GO:0003430 |
tolerance induction to self antigen(GO:0002513) growth plate cartilage chondrocyte growth(GO:0003430) |
0.3 |
1.3 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 |
0.9 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.3 |
2.3 |
GO:0048023 |
positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.3 |
3.6 |
GO:0048664 |
neuron fate determination(GO:0048664) |
0.3 |
2.7 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
0.2 |
0.7 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 |
0.6 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
0.2 |
0.9 |
GO:0032497 |
detection of lipopolysaccharide(GO:0032497) |
0.2 |
1.4 |
GO:0033504 |
floor plate development(GO:0033504) |
0.2 |
1.0 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.2 |
1.3 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
0.2 |
2.3 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.2 |
1.6 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 |
0.4 |
GO:1900041 |
intestinal D-glucose absorption(GO:0001951) negative regulation of interleukin-2 secretion(GO:1900041) terminal web assembly(GO:1902896) |
0.1 |
0.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 |
0.4 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 |
1.0 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
0.1 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 |
1.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
0.1 |
0.6 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
0.1 |
2.0 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
0.1 |
1.6 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
0.1 |
8.3 |
GO:0051592 |
response to calcium ion(GO:0051592) |
0.1 |
0.2 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
0.1 |
2.1 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 |
0.8 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.1 |
0.6 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 |
2.3 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.1 |
0.9 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
0.0 |
0.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
0.0 |
0.4 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.0 |
1.1 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
0.0 |
1.0 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 |
0.4 |
GO:0045618 |
positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 |
1.3 |
GO:0045620 |
negative regulation of lymphocyte differentiation(GO:0045620) |
0.0 |
0.7 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
0.0 |
1.2 |
GO:0000381 |
regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 |
1.2 |
GO:0015914 |
phospholipid transport(GO:0015914) |
0.0 |
1.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
0.0 |
0.1 |
GO:0015791 |
polyol transport(GO:0015791) |
0.0 |
1.0 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
0.0 |
0.6 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
0.0 |
0.1 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
0.0 |
0.1 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
0.0 |
0.3 |
GO:0045070 |
protein peptidyl-prolyl isomerization(GO:0000413) positive regulation of viral genome replication(GO:0045070) |
0.0 |
0.2 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
0.0 |
0.7 |
GO:0046847 |
filopodium assembly(GO:0046847) |
0.0 |
0.4 |
GO:0006378 |
mRNA polyadenylation(GO:0006378) |
0.0 |
1.4 |
GO:0009411 |
response to UV(GO:0009411) |
0.0 |
0.5 |
GO:0022904 |
respiratory electron transport chain(GO:0022904) |
0.0 |
0.4 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |